Thrombotic thrombocytopenic purpura surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Xyz}} | {{Xyz}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{S.G.}} | ||
==Overview== | ==Overview== |
Revision as of 20:52, 25 September 2018
Xyz Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thrombotic thrombocytopenic purpura surgery On the Web |
American Roentgen Ray Society Images of Thrombotic thrombocytopenic purpura surgery |
Risk calculators and risk factors for Thrombotic thrombocytopenic purpura surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
The mainstay of treatment for TTP is medical therapy. Surgery is usually reserved for patients with either no cure with plasma treatments and medicines.
Indications
- Surgery is not the first-line treatment option for patients withTTP when plasma treatments and medicines do not cure TTP, surgury is needed.[1]
Surgery
- Surgery is not the first-line treatment option for patients withTTP. Sometimes spelenectomy is needed, because the antibodies is made by cell in spleen that block ADAMTS13 enzyme activity.